333 related articles for article (PubMed ID: 33213216)
41. Reducing inappropriate polypharmacy: the process of deprescribing.
Scott IA; Hilmer SN; Reeve E; Potter K; Le Couteur D; Rigby D; Gnjidic D; Del Mar CB; Roughead EE; Page A; Jansen J; Martin JH
JAMA Intern Med; 2015 May; 175(5):827-34. PubMed ID: 25798731
[TBL] [Abstract][Full Text] [Related]
42. [MEDICATIONS DEPRESCRIBING IN ELDERLY NURSING HOME RESIDENTS].
Aizen E; Hindawil E; Hijazi M; Merih A; Shahla H; Elyounes AA
Harefuah; 2016 Mar; 155(3):145-9, 197. PubMed ID: 27305746
[TBL] [Abstract][Full Text] [Related]
43. Medication review and deprescribing in different healthcare settings: a position statement from an Italian scientific consortium.
Carollo M; Boccardi V; Crisafulli S; Conti V; Gnerre P; Miozzo S; Omodeo Salè E; Pieraccini F; Zamboni M; Marengoni A; Onder G; Trifirò G;
Aging Clin Exp Res; 2024 Mar; 36(1):63. PubMed ID: 38459218
[TBL] [Abstract][Full Text] [Related]
44. Inappropriate polypharmacy management versus deprescribing: A review on their relationship.
Zidan A; Awaisu A
Basic Clin Pharmacol Toxicol; 2024 Jan; 134(1):6-14. PubMed ID: 37350370
[TBL] [Abstract][Full Text] [Related]
45. Attitudes towards polypharmacy and medication withdrawal among older inpatients in Italy.
Galazzi A; Lusignani M; Chiarelli MT; Mannucci PM; Franchi C; Tettamanti M; Reeve E; Nobili A
Int J Clin Pharm; 2016 Apr; 38(2):454-61. PubMed ID: 26951120
[TBL] [Abstract][Full Text] [Related]
46. Thoughtful Prescribing and Deprescribing.
Pravodelov V
Med Clin North Am; 2020 Sep; 104(5):751-765. PubMed ID: 32773043
[TBL] [Abstract][Full Text] [Related]
47. Deprescribing in palliative care.
Thompson J
Clin Med (Lond); 2019 Jul; 19(4):311-314. PubMed ID: 31308110
[TBL] [Abstract][Full Text] [Related]
48. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
McIntyre C; McQuillan R; Bell C; Battistella M
Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321
[TBL] [Abstract][Full Text] [Related]
49. Deprescribing of non-antiretroviral therapy in HIV-infected patients.
Blanco JR; Morillo R; Abril V; Escobar I; Bernal E; Folguera C; Brañas F; Gimeno M; Ibarra O; Iribarren JA; Lázaro A; Mariño A; Martín MT; Martinez E; Ortega L; Olalla J; Robustillo A; Sanchez-Conde M; Rodriguez MA; de la Torre J; Sanchez-Rubio J; Tuset M;
Eur J Clin Pharmacol; 2020 Mar; 76(3):305-318. PubMed ID: 31865412
[TBL] [Abstract][Full Text] [Related]
50. A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative review.
Sawan M; Reeve E; Turner J; Todd A; Steinman MA; Petrovic M; Gnjidic D
Expert Rev Clin Pharmacol; 2020 Mar; 13(3):233-245. PubMed ID: 32056451
[No Abstract] [Full Text] [Related]
51. DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities.
Ailabouni N; Mangin D; Nishtala PS
Int J Clin Pharm; 2019 Feb; 41(1):167-178. PubMed ID: 30659492
[TBL] [Abstract][Full Text] [Related]
52. Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial.
Balsom C; Pittman N; King R; Kelly D
Int J Clin Pharm; 2020 Aug; 42(4):1153-1167. PubMed ID: 32494991
[TBL] [Abstract][Full Text] [Related]
53. Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study.
Pasina L; Brignolo Ottolini B; Cortesi L; Tettamanti M; Franchi C; Marengoni A; Mannucci PM; Nobili A;
Med Princ Pract; 2019; 28(6):501-508. PubMed ID: 30889568
[TBL] [Abstract][Full Text] [Related]
54. Health Outcomes of Deprescribing Interventions Among Older Residents in Nursing Homes: A Systematic Review and Meta-analysis.
Kua CH; Mak VSL; Huey Lee SW
J Am Med Dir Assoc; 2019 Mar; 20(3):362-372.e11. PubMed ID: 30581126
[TBL] [Abstract][Full Text] [Related]
55. Polypharmacy in chronic diseases-Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support (PRIMA-eDS): study protocol for a randomized controlled trial.
Sönnichsen A; Trampisch US; Rieckert A; Piccoliori G; Vögele A; Flamm M; Johansson T; Esmail A; Reeves D; Löffler C; Höck J; Klaassen-Mielke R; Trampisch HJ; Kunnamo I
Trials; 2016 Jan; 17():57. PubMed ID: 26822311
[TBL] [Abstract][Full Text] [Related]
56. Polypharmacy in the Hospitalized Older Adult: Considerations for Safe and Effective Treatment.
DiConti-Gibbs A; Chen KY; Coffey CE
Clin Geriatr Med; 2022 Nov; 38(4):667-684. PubMed ID: 36210083
[TBL] [Abstract][Full Text] [Related]
57. Deprescribing in Older Adults With Cancer and Limited Life Expectancy: An Integrative Review.
Brokaar EJ; van den Bos F; Visser LE; Portielje JEA
Am J Hosp Palliat Care; 2022 Jan; 39(1):86-100. PubMed ID: 33739162
[TBL] [Abstract][Full Text] [Related]
58. Prescribing and deprescribing in older people with life-limiting illnesses receiving hospice care at the end of life: A longitudinal, retrospective cohort study.
Alwidyan T; McCorry NK; Black C; Coulter R; Forbes J; Parsons C
Palliat Med; 2024 Jan; 38(1):121-130. PubMed ID: 38032069
[TBL] [Abstract][Full Text] [Related]
59. Electronic Medication Management System Introduction and Deprescribing Practice in Post-Acute Care.
Winata S; Liacos M; Crabtree A; Page A; Moran C
J Am Med Dir Assoc; 2021 Jan; 22(1):90-95. PubMed ID: 33234446
[TBL] [Abstract][Full Text] [Related]
60. [Polypharmacy and deprescribing in cardiology].
Bobbio M
G Ital Cardiol (Rome); 2020 Oct; 21(10):801-806. PubMed ID: 32968317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
